DBV Technologies (DBVT) EBT (2014 - 2026)
DBV Technologies (DBVT) reported EBT of -$47.4 million for Q1 2026, down 74.91% year-over-year from -$188.9 million in Q1 2025, and down 6.62% on a QoQ basis from -$44.5 million in Q4 2025.
DBV Technologies (DBVT) has 12 years of EBT data on file, last reported at -$47.4 million in Q1 2026.
- Quarterly EBT fell 74.91% year-over-year to -$47.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$166.8 million (down 46.73% YoY) and the FY2025 annual result came in at -$146.5 million, down 28.62% from the prior year.
- EBT declined to -$47.4 million in Q1 2026 per DBVT's latest filing, from -$44.5 million in the prior quarter.
- Across five years, EBT topped out at -$11.2 million in Q4 2023 and bottomed at -$47.4 million in Q1 2026.
- The 5-year median for EBT is -$27.1 million (2025), against an average of -$28.0 million.
- The widest annual swing landed in 2022, when EBT plunged 187.63%; it then surged 71.49% in 2023.
- Tracing DBVT's EBT over 5 years: stood at -$39.3 million in 2022, then surged by 71.49% to -$11.2 million in 2023, then tumbled by 105.58% to -$23.0 million in 2024, then sank by 93.22% to -$44.5 million in 2025, then declined by 6.62% to -$47.4 million in 2026.
- Per Business Quant, the three latest DBVT EBT figures stand at -$47.4 million (Q1 2026), -$44.5 million (Q4 2025), and -$33.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -47.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.40 Mn |
| Dec 31, 2025 | -44.46 Mn |
| Sep 30, 2025 | -33.16 Mn |
| Jun 30, 2025 | -41.76 Mn |
| Mar 31, 2025 | -27.10 Mn |
| Dec 31, 2024 | -23.01 Mn |
| Sep 30, 2024 | -30.44 Mn |
| Jun 30, 2024 | -33.12 Mn |
| Mar 31, 2024 | -27.30 Mn |
| Dec 31, 2023 | -11.19 Mn |
| Sep 30, 2023 | -16.74 Mn |
| Jun 30, 2023 | -24.23 Mn |
| Mar 31, 2023 | -20.56 Mn |
| Dec 31, 2022 | -39.26 Mn |
| Sep 30, 2022 | -17.29 Mn |
| Jun 30, 2022 | -23.04 Mn |
| Mar 31, 2022 | -16.62 Mn |
| Dec 31, 2021 | -13.65 Mn |
| Sep 30, 2021 | -24.03 Mn |
| Jun 30, 2021 | -31.09 Mn |
| Mar 31, 2021 | -29.42 Mn |
| Dec 31, 2020 | -39.51 Mn |
| Sep 30, 2020 | -30.95 Mn |
| Jun 30, 2020 | -48.20 Mn |
| Mar 31, 2020 | -40.91 Mn |
| Sep 30, 2019 | -131.31 Mn |
| Dec 31, 2018 | -57.75 Mn |
| Sep 30, 2018 | -50.49 Mn |
| Jun 30, 2016 | -55.21 Mn |
| Dec 31, 2015 | -16.35 Mn |
| Jun 30, 2015 | -15.81 Mn |
| Dec 31, 2014 | -15.10 Mn |
| Jun 30, 2014 | -16.08 Mn |